BSECompany Update2 Nov 2026 · 2 Nov 2026, 05:31 pm

PFA

Shree Ganesh Biotech (India) Ltd · 539470

✦ AI SummaryResults

Shree Ganesh Biotech (India) Ltd has informed BSE that it does not have any unutilized funds from public issues, rights issues, or QIPs as of 30th September 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

8ee61520-7a82-4abf-aed4-7c9c70173023.pdf

pdf

Download →
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Date: 02.11.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, The Calcutta Stock Metropolitan Stock Exchange P J Tower, Dalal Exchange Ltd, of India Limited Street 7, Lyons Range, Vibgyor Towers, 4th floor, Plot Mumbai-400001 Kolkata - 700001 No C 62, Opp. Trident Hotel Bandra Kurla Complex, Bandra (E), Mumbai – 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES Dear Sir/Madam, Sub: Disclosure under Regulation 32(1) of SEBI (listing Obligation and Disclosure Requirements) Regulations, 2015 Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 30th September 2026, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You. Yours faithfully FOR, SHREE GANESH BIOTECH (INDIA) LIMITED Aman Patel Wholetime Director